Durham, NC · Founded 2018 · Privately Held (backing)
Developer of novel antineoplastic therapeutics designed to create remedial medicines to targets previously believed undruggable. Ten63 Therapeutics is based in Durham, NC and was founded in 2018. It was valued at $979 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $50.5 million across 1 recorded round; the latest was a $2.1 million seed round in Jan 2021.
PMV mark · valuation
$979.0M
Oct 2026
Priced at
its later-stage round
Jan 2025
Total raised
$50.5M
Last round
Seed Round
Jan 2021
Cap table — not yet on record
Ten63 Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ten63 Therapeutics with a free account
·The complete investor list: 20 names
·Watch Ten63 Therapeutics: the Monday email on marks, rounds and moves
Where does Ten63 Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Ten63 Therapeutics's 1 recorded funding rounds.
